复发性-话题@MedSci

#复发性#

452篇内容 | 2480人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909850, encodeId=a8961909850c4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, objectType=article, longId=203653, objectId=a1a820365319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1a820365319, replyNumber=0, likeNumber=95, createdTime=2021-05-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1a820365319, moduleTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1a820365319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909894, encodeId=92d81909894c3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：Loncastuximab tesirine可有效治疗复发性/难治性DLBCL！, objectType=article, longId=211283, objectId=6e722112837b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e722112837b, replyNumber=0, likeNumber=67, createdTime=2021-11-09, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e722112837b, moduleTitle=Lancet oncol：Loncastuximab tesirine可有效治疗复发性/难治性DLBCL！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e722112837b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909873, encodeId=df9219098e31b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：3期试验| 内镜手术 vs 强化放疗治疗复发性鼻咽癌患者的预后, objectType=article, longId=207184, objectId=f7be20e184ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7be20e184ff, replyNumber=0, likeNumber=60, createdTime=2021-02-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7be20e184ff, moduleTitle=Lancet Oncol：3期试验| 内镜手术 vs 强化放疗治疗复发性鼻咽癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7be20e184ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909892, encodeId=39b8190989299, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Stroke：颈动脉狭窄与复发性缺血性卒中的关系, objectType=article, longId=211013, objectId=e279211013d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e279211013d4, replyNumber=0, likeNumber=78, createdTime=2021-11-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e279211013d4, moduleTitle=Stroke：颈动脉狭窄与复发性缺血性卒中的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e279211013d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909839, encodeId=a99f19098397d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高, objectType=article, longId=200150, objectId=af16200150b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af16200150b6, replyNumber=0, likeNumber=68, createdTime=2021-02-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af16200150b6, moduleTitle=Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af16200150b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909825, encodeId=76ba190982530, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：采用CD19/CD20 CAR T细胞治疗难治性/复发性非霍奇金淋巴瘤, objectType=article, longId=196286, objectId=035019628601, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=035019628601, replyNumber=0, likeNumber=71, createdTime=2021-05-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=035019628601, moduleTitle=Blood：采用CD19/CD20 CAR T细胞治疗难治性/复发性非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=035019628601)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909853, encodeId=5b4c190985396, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：依鲁替尼、Obinutuzumab和Venotclax联合治疗复发性/初治套细胞淋巴瘤, objectType=article, longId=204048, objectId=2fa5204048fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fa5204048fb, replyNumber=0, likeNumber=68, createdTime=2020-12-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fa5204048fb, moduleTitle=Blood：依鲁替尼、Obinutuzumab和Venotclax联合治疗复发性/初治套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fa5204048fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909869, encodeId=57181909869e2, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, objectType=article, longId=206078, objectId=28d22060e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d22060e857, replyNumber=0, likeNumber=60, createdTime=2021-06-21, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d22060e857, moduleTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d22060e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909861, encodeId=d533190986107, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, objectType=article, longId=205454, objectId=6ca6205454ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca6205454ce, replyNumber=0, likeNumber=84, createdTime=2021-04-10, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca6205454ce, moduleTitle=NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca6205454ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909882, encodeId=ecb41909882cd, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！, objectType=article, longId=208161, objectId=dc7d20816104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc7d20816104, replyNumber=0, likeNumber=68, createdTime=2021-11-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc7d20816104, moduleTitle=Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc7d20816104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909887, encodeId=b0de190988e75, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌, objectType=article, longId=208795, objectId=2961208e956a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2961208e956a, replyNumber=0, likeNumber=75, createdTime=2021-06-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2961208e956a, moduleTitle=CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2961208e956a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909847, encodeId=196e190984e56, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=CP101预防复发性艰难梭菌感染：临床试验已取得积极结果, objectType=article, longId=202656, objectId=c21c20265668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c21c20265668, replyNumber=0, likeNumber=64, createdTime=2021-01-10, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c21c20265668, moduleTitle=CP101预防复发性艰难梭菌感染：临床试验已取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c21c20265668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909812, encodeId=8aaa190981224, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, objectType=article, longId=192943, objectId=28a119294391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a119294391, replyNumber=0, likeNumber=80, createdTime=2020-12-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a119294391, moduleTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a119294391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909819, encodeId=83d2190981968, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Urol：为什么预防复发性尿路感染不会导致更少的肾脏瘢痕？, objectType=article, longId=195046, objectId=8cb319504611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cb319504611, replyNumber=0, likeNumber=74, createdTime=2020-06-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cb319504611, moduleTitle=J Urol：为什么预防复发性尿路感染不会导致更少的肾脏瘢痕？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cb319504611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909820, encodeId=6ae71909820b6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Expert Rev Anti Infect Ther：益生菌和蔓越莓补充剂可预防绝经前妇女复发性单纯性尿路感染, objectType=article, longId=195077, objectId=69da1950e774, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69da1950e774, replyNumber=0, likeNumber=71, createdTime=2020-06-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69da1950e774, moduleTitle=Expert Rev Anti Infect Ther：益生菌和蔓越莓补充剂可预防绝经前妇女复发性单纯性尿路感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69da1950e774)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909855, encodeId=be861909855a1, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Gut：兰索拉唑和法莫替丁在预防复发性特发性胃十二指肠溃疡出血方向的效果, objectType=article, longId=204145, objectId=636a2041453a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=636a2041453a, replyNumber=0, likeNumber=79, createdTime=2021-10-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=636a2041453a, moduleTitle=Gut：兰索拉唑和法莫替丁在预防复发性特发性胃十二指肠溃疡出血方向的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=636a2041453a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909822, encodeId=b0891909822a4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Rheumatol：影响复发性多软骨炎主动脉及其分支的大血管血管炎, objectType=article, longId=195488, objectId=a504195488a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a504195488a9, replyNumber=0, likeNumber=75, createdTime=2020-10-23, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a504195488a9, moduleTitle=J Rheumatol：影响复发性多软骨炎主动脉及其分支的大血管血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a504195488a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909817, encodeId=7de0190981e4f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗, objectType=article, longId=194917, objectId=cfd319491ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd319491ed0, replyNumber=0, likeNumber=82, createdTime=2020-10-27, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd319491ed0, moduleTitle=又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd319491ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909871, encodeId=37b819098e14d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性卵巢癌：Rucaparib 维持治疗优势分析, objectType=article, longId=206094, objectId=3892206094de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3892206094de, replyNumber=0, likeNumber=90, createdTime=2021-05-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3892206094de, moduleTitle=复发性卵巢癌：Rucaparib 维持治疗优势分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3892206094de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909829, encodeId=7f2f1909829c9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, objectType=article, longId=197252, objectId=947b19e25234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947b19e25234, replyNumber=0, likeNumber=65, createdTime=2020-11-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947b19e25234, moduleTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947b19e25234)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较

2021-05-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：Loncastuximab tesirine可有效治疗复发性/难治性DLBCL！

2021-11-09

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：3期试验| 内镜手术 vs 强化放疗治疗复发性鼻咽癌患者的预后

2021-02-18

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Stroke：颈动脉狭窄与复发性缺血性卒中的关系

2021-11-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet：Liso-cel治疗复发性/难治性大B细胞淋巴瘤活性好、安全性高

2021-02-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：采用CD19/CD20 CAR T细胞治疗难治性/复发性非霍奇金淋巴瘤

2021-05-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：依鲁替尼、Obinutuzumab和Venotclax联合治疗复发性/初治套细胞淋巴瘤

2020-12-14

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案

2021-06-21

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：白介素-1阻滞剂Rilonacept用于复发性心包炎的治疗

2021-04-10

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：复发性/转移性头颈鳞状细胞癌患者的两种一线化疗方案对比！

2021-11-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌

2021-06-07

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

CP101预防复发性艰难梭菌感染：临床试验已取得积极结果

2021-01-10

仁心济世 (审核中...)

前往app查看评论内容

#复发性#

Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比

2020-12-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Urol：为什么预防复发性尿路感染不会导致更少的肾脏瘢痕？

2020-06-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Expert Rev Anti Infect Ther：益生菌和蔓越莓补充剂可预防绝经前妇女复发性单纯性尿路感染

2020-06-25

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Gut：兰索拉唑和法莫替丁在预防复发性特发性胃十二指肠溃疡出血方向的效果

2021-10-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Rheumatol：影响复发性多软骨炎主动脉及其分支的大血管血管炎

2020-10-23

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗

2020-10-27

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性卵巢癌：Rucaparib 维持治疗优势分析

2021-05-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究

2020-11-01

科室
- - 订阅+
  - 更多科室
工具
服务